Health

NIH partners with WHO to make COVID-19Tech available worldwide

This partnership will enable international manufacturers to benefit people living in low- and middle-income countries using technologies for the potential development of COVID-19 vaccines, treatments and diagnostics.

The National Institutes of Health (NIH) recently announced a pool of drug patents in collaboration with the World Health Organization (WHO) and to make COVID-19 health technology available worldwide.

This announcement was made at the 2nd Global COVID-19 Summit held on May 5th.

NIH License 11 COVID-19 According to the Healthcare Finance article, research tools and initial vaccines and diagnostic candidates for the drug patent pool via WHO’s COVID-19 Technology Access Pool (C-TAP).

These licenses allow international manufacturers to benefit people living in low- and middle-income countries using technologies for the potential development of COVID-19 vaccines, treatments and diagnostics.

C-TAP provides a global supply of COVID-19 vaccines, treatments and diagnostics by facilitating the sharing of intellectual property, knowledge and data with quality-guaranteed manufacturers capable of expanding production. We aim to promote it.

“We can manage COVID-19 globally and address future public health threats only if all communities, including the most vulnerable, have access to life-saving treatments, vaccines and diagnostics.” Health and Welfare Secretary Xavier Besera said in the report. “Sharing scientific knowledge and health techniques with C-TAP to facilitate the development of critical medical measures is what we take to assist our global partners in the common fight against this catastrophic disease. Another step you are doing. “

The agreement will increase access to these technologies with the aim of leading to the development of off-the-shelf products that meet current and future public health needs.

ExBulletin

NIH partners with WHO to make COVID-19Tech available worldwide